ProMIS Neurosciences Inc. (PMN): EPS (Diluted)
-$22.61
Year ended 2025-12-31
| Period ended | EPS (Diluted) | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$22.61 | n/m | 2026-03-25, From 2025-01-01 |
| 2024-12-31 | $2.63 | n/c | 2026-03-25, From 2024-01-01 |
| 2023-12-31 | -$1.07 | n/m | 2025-03-31, From 2023-01-01 |
| 2022-12-31 | -$2.41 | n/m | 2024-04-01, From 2022-01-01 |
| 2021-12-31 | -$1.69 | n/a | 2023-03-08, From 2021-01-01 |
EPS (Diluted) at similar companies
| Company | Year ended | EPS (Diluted) | Change YoY |
|---|---|---|---|
| ProMIS Neurosciences Inc. (PMN) | 2025-12-31 | -$22.61 | n/m |
| Soligenix, Inc. (SNGX) | 2025-12-31 | -$2.14 | n/m |
| Indaptus Therapeutics, Inc. (INDP) | 2025-12-31 | -$21.58 | n/m |
| Earth Science Tech, Inc. (ETST) | 2026-03-31 | $0.012 | +9.1% |
| Kala Bio, Inc. (KALA) | 2025-12-31 | -$3.31 | n/m |
| Can-Fite BioPharma Ltd. (CANF) | 2025-12-31 | -$5.97 | n/m |
| Nanoviricides, Inc. (NNVC) | 2025-06-30 | -$0.63 | n/m |
| FibroBiologics, Inc. (FBLG) | 2025-12-31 | -$0.42 | n/m |
| IGC Pharma, Inc. (IGC) | 2025-03-31 | -$0.09 | n/m |
Compare PMN, SNGX, INDP, ETST side by side · Screen every company in Pharmaceutical Preparations ↗